Spotlight on Diabetes
On September 25, 2008, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating Type 1 diabetes, formerly known as juvenile diabetes. They learned about CIRM-funded stem cell research from Emmanuel Baetge, current treatments for diabetes from Peter Butler, and life with diabetes from Joelle Johnson.
- Welcoming remarks, Robert Klein, JD, chair of the governing board
- Peter Butler, M.D., director of the Larry Hillblom Islet Research Center at the University of California, Los Angeles
- Emmanuel Baetge, Ph.D., vice president and chief scientific officer for Novocell Inc.
- Joelle Johnson, patient with type 1 diabetes
